PSYCHEMEDICS CORP (PMD) Stock Price, Quote, News and Overview
NASDAQ:PMD - Nasdaq - US7443752057 - Common Stock - Currency: USD
PMD Quote, Performance and Key Statistics
2.67
-0.05 (-1.84%)
The current stock price of PMD is 2.67 USD. In the past month the price increased by 13.86%. In the past year, price decreased by -10.4%.
PMD Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.17 | 89.59B | ||
| CI | THE CIGNA GROUP | 10.84 | 81.30B | ||
| LH | LABCORP HOLDINGS INC | 18.37 | 23.11B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.49 | 20.62B | ||
| FMS | FRESENIUS MEDICAL CARE-ADR | 12.35 | 14.78B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 110.68 | 14.45B | ||
| DVA | DAVITA INC | 14.18 | 10.38B | ||
| HIMS | HIMS & HERS HEALTH INC | 54.23 | 9.71B | ||
| GH | GUARDANT HEALTH INC | N/A | 7.30B | ||
| CHE | CHEMED CORP | 20.37 | 6.67B | ||
| RDNT | RADNET INC | 190.67 | 5.28B | ||
| CRVL | CORVEL CORP | 48.86 | 4.56B |
Related stock screener links
About PMD
Company Profile
Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. The company is headquartered in Acton, Massachusetts and currently employs 116 full-time employees. The firm provides testing services for the detection of drugs of abuse through the analysis of hair samples. Its testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The firm customizes its enzyme immunoassay (EIA) procedures to drug test hair samples. The company provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phenylcyclohexyl piperidine (PCP), amphetamines (including ecstasy, eve, and Adderall), opiates (including heroin, hydrocodone, hydromorphone, oxycodone and codeine), synthetic cannabinoids (including K2, Spice, Blaze), benzodiazepines (Xanax, Valium, and Ativan), nicotine, Fentanyl, and alcohol. The firm markets its corporate drug testing services through its own sales force, distributors, and partners. The company markets its home drug testing service, PDT-90, through the Internet.
Company Info
PSYCHEMEDICS CORP
125 Nagog Park
Acton MASSACHUSETTS 01720 US
CEO: Raymond C. Kubacki
Employees: 116
Phone: 19782068220
PSYCHEMEDICS CORP / PMD FAQ
What is the stock price of PSYCHEMEDICS CORP today?
The current stock price of PMD is 2.67 USD. The price decreased by -1.84% in the last trading session.
What is the ticker symbol for PSYCHEMEDICS CORP stock?
The exchange symbol of PSYCHEMEDICS CORP is PMD and it is listed on the Nasdaq exchange.
On which exchange is PMD stock listed?
PMD stock is listed on the Nasdaq exchange.
What is PSYCHEMEDICS CORP worth?
PSYCHEMEDICS CORP (PMD) has a market capitalization of 15.73M USD. This makes PMD a Nano Cap stock.
How many employees does PSYCHEMEDICS CORP have?
PSYCHEMEDICS CORP (PMD) currently has 116 employees.
What are the support and resistance levels for PSYCHEMEDICS CORP (PMD) stock?
PSYCHEMEDICS CORP (PMD) has a support level at 2.4. Check the full technical report for a detailed analysis of PMD support and resistance levels.
Should I buy PSYCHEMEDICS CORP (PMD) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of PMD, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of PMD, evaluating the profitability, health, valuation and growth aspects
- PSYCHEMEDICS CORP (PMD) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- PSYCHEMEDICS CORP (PMD) Sales and EPS estimates to see what analysts future expectations are.
- PSYCHEMEDICS CORP (PMD) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- PSYCHEMEDICS CORP (PMD) Insider and Institutional Ownership to learn about the owners and their transactions.
- PSYCHEMEDICS CORP (PMD) Stock Chart to make your own analysis
- PSYCHEMEDICS CORP (PMD) Latest news and press-releases to stay up to date.
Does PSYCHEMEDICS CORP (PMD) stock pay dividends?
PSYCHEMEDICS CORP (PMD) has a dividend yield of 12.67%. The yearly dividend amount is currently 0.14. Check the full fundamental report for a detailed analysis of PMD dividend history, reliability and sustainability.
What is the Price/Earnings (PE) ratio of PSYCHEMEDICS CORP (PMD)?
PSYCHEMEDICS CORP (PMD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.51).
PMD Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to PMD. When comparing the yearly performance of all stocks, PMD turns out to be only a medium performer in the overall market: it outperformed 54.69% of all stocks.
PMD Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to PMD. The financial health of PMD is average, but there are quite some concerns on its profitability.
PMD Financial Highlights
Over the last trailing twelve months PMD reported a non-GAAP Earnings per Share(EPS) of -0.51. The EPS increased by 24.38% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -30.45% | ||
| ROE | -54.99% | ||
| Debt/Equity | 0.09 |
PMD Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 100% to PMD. The Buy consensus is the average rating of analysts ratings from 1 analysts.